Arrowhead Pharmaceuticals to open UK sites in SCA2 trial
The pharmaceutical company Arrowhead Therapeutics has begun recruitment for their phase 1 randomised placebo-controlled trial of ARO-ATXN2 in adults with SCA2. The programme is a partnership with the pharmaceutical company […]
Arrowhead Pharmaceuticals to open UK sites in SCA2 trial Read More »